
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The COVID-19 Vaccines: Recent Development, Challenges and Prospects
Yuxin Yan, Yoongxin Pang, Zhuoyi Lyu, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 349-349
Open Access | Times Cited: 79
Yuxin Yan, Yoongxin Pang, Zhuoyi Lyu, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 349-349
Open Access | Times Cited: 79
Showing 1-25 of 79 citing articles:
Global COVID-19 Vaccine Acceptance: A Systematic Review of Associated Social and Behavioral Factors
Choudhary Sobhan Shakeel, Amenah Abdul Mujeeb, Muhammad Shaheer Mirza, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 110-110
Open Access | Times Cited: 141
Choudhary Sobhan Shakeel, Amenah Abdul Mujeeb, Muhammad Shaheer Mirza, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 110-110
Open Access | Times Cited: 141
An overview on the treatments and prevention against COVID-19
Yunes Panahi, Armita Mahdavi Gorabi, Sona Talaei, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 48
Yunes Panahi, Armita Mahdavi Gorabi, Sona Talaei, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 48
Vaccine cold chain management and cold storage technology to address the challenges of vaccination programs
Nugroho Agung Pambudi, Alfan Sarifudin, Indra Mamad Gandidi, et al.
Energy Reports (2021) Vol. 8, pp. 955-972
Open Access | Times Cited: 88
Nugroho Agung Pambudi, Alfan Sarifudin, Indra Mamad Gandidi, et al.
Energy Reports (2021) Vol. 8, pp. 955-972
Open Access | Times Cited: 88
COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions
Wajihul Hasan Khan, Zohra Hashmi, Aditya Goel, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 85
Wajihul Hasan Khan, Zohra Hashmi, Aditya Goel, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 85
Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary
Marie Tré‐Hardy, Roberto Cupaiolo, Alain Wilmet, et al.
Journal of Infection (2021) Vol. 83, Iss. 5, pp. 559-564
Open Access | Times Cited: 71
Marie Tré‐Hardy, Roberto Cupaiolo, Alain Wilmet, et al.
Journal of Infection (2021) Vol. 83, Iss. 5, pp. 559-564
Open Access | Times Cited: 71
Forecasting fully vaccinated people against COVID-19 and examining future vaccination rate for herd immunity in the US, Asia, Europe, Africa, South America, and the World
Pınar Cihan
Applied Soft Computing (2021) Vol. 111, pp. 107708-107708
Open Access | Times Cited: 67
Pınar Cihan
Applied Soft Computing (2021) Vol. 111, pp. 107708-107708
Open Access | Times Cited: 67
COVID-19 Vaccination Attitudes, Perceptions, and Side Effect Experiences in Malaysia: Do Age, Gender, and Vaccine Type Matter?
Mohamed Hassan Elnaem, Nor Hidayah Mohd Taufek, Norny Syafinaz Ab Rahman, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1156-1156
Open Access | Times Cited: 60
Mohamed Hassan Elnaem, Nor Hidayah Mohd Taufek, Norny Syafinaz Ab Rahman, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1156-1156
Open Access | Times Cited: 60
Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan
Bilal Mahmood Beg, Tariq Hussain, Mehmood Ahmad, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0266028-e0266028
Open Access | Times Cited: 60
Bilal Mahmood Beg, Tariq Hussain, Mehmood Ahmad, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0266028-e0266028
Open Access | Times Cited: 60
Development and validation of a sensitive, fast and simple LC-MS / MS method for the quantitation of favipiravir in human serum
Duygu Eryavuz Onmaz, Sedat Abuşoğlu, Mustafa Onmaz, et al.
Journal of Chromatography B (2021) Vol. 1176, pp. 122768-122768
Open Access | Times Cited: 52
Duygu Eryavuz Onmaz, Sedat Abuşoğlu, Mustafa Onmaz, et al.
Journal of Chromatography B (2021) Vol. 1176, pp. 122768-122768
Open Access | Times Cited: 52
Strawberry and Ginger Silver Nanoparticles as Potential Inhibitors for SARS-CoV-2 Assisted by In Silico Modeling and Metabolic Profiling
Mohammad M. Al‐Sanea, Narek Abelyan, Mohamed A. Abdelgawad, et al.
Antibiotics (2021) Vol. 10, Iss. 7, pp. 824-824
Open Access | Times Cited: 45
Mohammad M. Al‐Sanea, Narek Abelyan, Mohamed A. Abdelgawad, et al.
Antibiotics (2021) Vol. 10, Iss. 7, pp. 824-824
Open Access | Times Cited: 45
An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19)
Armina Alagheband Bahrami, Ali Azargoonjahromi, Samin Sadraei, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 27
Armina Alagheband Bahrami, Ali Azargoonjahromi, Samin Sadraei, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 27
Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2
Jean‐Louis Bayart, Laure Morimont, Mélanie Closset, et al.
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1340-1340
Open Access | Times Cited: 38
Jean‐Louis Bayart, Laure Morimont, Mélanie Closset, et al.
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1340-1340
Open Access | Times Cited: 38
RETRACTED: Why are we vaccinating children against COVID-19?
Ronald N. Kostoff, Daniela Călina, Darja Kanduc, et al.
Toxicology Reports (2021) Vol. 8, pp. 1665-1684
Open Access | Times Cited: 35
Ronald N. Kostoff, Daniela Călina, Darja Kanduc, et al.
Toxicology Reports (2021) Vol. 8, pp. 1665-1684
Open Access | Times Cited: 35
Public attitudes and influencing factors toward COVID-19 vaccination for adolescents/children: a scoping review
Ying Liu, Qilin Ma, H Liu, et al.
Public Health (2022) Vol. 205, pp. 169-181
Open Access | Times Cited: 26
Ying Liu, Qilin Ma, H Liu, et al.
Public Health (2022) Vol. 205, pp. 169-181
Open Access | Times Cited: 26
Egg Yolk Antibody for Passive Immunization: Status, Challenges, and Prospects
Huiwen Wang, Qixin Zhong, Jun Lin
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 13, pp. 5053-5061
Closed Access | Times Cited: 12
Huiwen Wang, Qixin Zhong, Jun Lin
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 13, pp. 5053-5061
Closed Access | Times Cited: 12
COVID-19 Vaccination Acceptance Among Chinese Population and Its Implications for the Pandemic: A National Cross-Sectional Study
Jian Wu, Mingze Ma, Yudong Miao, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 21
Jian Wu, Mingze Ma, Yudong Miao, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 21
Mapping the Mechanical and Immunological Profiles of Polymeric Microneedles to Enable Vaccine and Immunotherapy Applications
Shrey Shah, Robert S. Oakes, Senta M. Kapnick, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Shrey Shah, Robert S. Oakes, Senta M. Kapnick, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations
Seong A Kim, Seohyun Kim, Gi Beom Kim, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6123-6123
Open Access | Times Cited: 13
Seong A Kim, Seohyun Kim, Gi Beom Kim, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6123-6123
Open Access | Times Cited: 13
Effect of inactivated COVID-19 vaccination on pregnancy outcomes following frozen-thawed embryo transfer: A retrospective cohort study
Jialyu Huang, Yiqi Liu, Han Zeng, et al.
International Immunopharmacology (2022) Vol. 114, pp. 109552-109552
Open Access | Times Cited: 11
Jialyu Huang, Yiqi Liu, Han Zeng, et al.
International Immunopharmacology (2022) Vol. 114, pp. 109552-109552
Open Access | Times Cited: 11
Effectiveness of behavioural interventions to influence COVID-19 outcomes: A scoping review
Takana M Silubonde-Moyana, Catherine E. Draper, Shane A. Norris
Preventive Medicine (2023) Vol. 172, pp. 107499-107499
Open Access | Times Cited: 6
Takana M Silubonde-Moyana, Catherine E. Draper, Shane A. Norris
Preventive Medicine (2023) Vol. 172, pp. 107499-107499
Open Access | Times Cited: 6
Designing a sustainable vaccine supply chain by considering demand substitution and value-added function during a pandemic outbreak
Samira Al-sadat Salari, Zeinab Sazvar
Computers & Industrial Engineering (2023) Vol. 187, pp. 109826-109826
Closed Access | Times Cited: 6
Samira Al-sadat Salari, Zeinab Sazvar
Computers & Industrial Engineering (2023) Vol. 187, pp. 109826-109826
Closed Access | Times Cited: 6
Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review
Muhammad Azharuddin Azali, Salmah Mohamed, Azian Harun, et al.
Journal of Genetic Engineering and Biotechnology (2022) Vol. 20, Iss. 1, pp. 98-98
Open Access | Times Cited: 10
Muhammad Azharuddin Azali, Salmah Mohamed, Azian Harun, et al.
Journal of Genetic Engineering and Biotechnology (2022) Vol. 20, Iss. 1, pp. 98-98
Open Access | Times Cited: 10
The status of COVID-19 vaccines in India: A review
Deepak Kumar Jha, Kumar Pranay, Samiksha, et al.
Vacunas (2023) Vol. 24, Iss. 3, pp. 218-247
Open Access | Times Cited: 5
Deepak Kumar Jha, Kumar Pranay, Samiksha, et al.
Vacunas (2023) Vol. 24, Iss. 3, pp. 218-247
Open Access | Times Cited: 5
Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines
Charlotte Dubé, Sarah Paris‐Robidas, Guadalupe Andreani, et al.
Vaccine (2022) Vol. 40, Iss. 30, pp. 4017-4025
Open Access | Times Cited: 9
Charlotte Dubé, Sarah Paris‐Robidas, Guadalupe Andreani, et al.
Vaccine (2022) Vol. 40, Iss. 30, pp. 4017-4025
Open Access | Times Cited: 9
Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
Vidya Niranjan, Anagha S Setlur, Chandrashekar Karunakaran, et al.
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1585-1608
Open Access | Times Cited: 9
Vidya Niranjan, Anagha S Setlur, Chandrashekar Karunakaran, et al.
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1585-1608
Open Access | Times Cited: 9